1380P Phase (Ph) II study of zanidatamab + chemotherapy (chemo) in first-line (1L) HER2 expressing gastroesophageal adenocarcinoma (GEA)

Authors :: Geoffrey Y. Ku
R. Mehta
Sun Young Rha
C. S. Denlinger
T. Mwatha
Yeul Hong Kim
Jaffer A. Ajani
K-W. Lee
Y-K. Kang
Elena Elimova
D-Y. Oh
S. Iqbal
Y. M. Seol
J. Grim
Source :: Annals of Oncology. 32:S1044-S1045
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Chemotherapy
Gastroesophageal adenocarcinoma
Oncology
business.industry
Phase (matter)
First line
medicine.medical_treatment
Cancer research
Medicine
Hematology
business

Full Text Access

Tools